Medpace
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.About MEDP
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.
MEDP Key Statistics
MEDP News
Medpace Holdings Inc ((MEDP)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...
Medpace Holdings Inc ((MEDP)), Radiopharm Theranostics Limited ((AU:RAD)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy:...
Medpace Holdings Inc ((MEDP)), Radiopharm Theranostics Limited ((AU:RAD)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy:...
Analyst ratings
57%
of 14 ratingsMore MEDP News
Tenax Therapeutics ((TENX)), Medpace Holdings Inc ((MEDP)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantag...
Medpace Holdings Inc ((MEDP)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...
Medpace Holdings (MEDP) has seen fresh attention from investors recently, with its stock posting a strong showing over the past month. Shares gained more than 2...
Key Points Medpace's revenue growth was strong last quarter. The company is building up a backlog as the clinical trial sector recovers. Shares of Medpace ar...
Medpace Holdings Inc. (NASDAQ:MEDP) posted better-than-expected third-quarter earnings on Thursday. The clinical contract research organization reported earnin...
Barclays analyst Luke Sergott raised the firm’s price target on Medpace (MEDP) to $485 from $425 and keeps an Underweight rating on the shares following the ear...
Medpace Holdings Inc ( (MEDP) ) has released its Q3 earnings. Here is a breakdown of the information Medpace Holdings Inc presented to its investors. Elevate Y...